chartexchange

PCVX
Vaxcyte, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
58.55USD-1.431%(-0.85)1,128,790
Pre-marketNov 18, 2026 8:16:30 AM EST
59.40USD0.000%(0.00)
After-hoursNov 18, 2026 4:05:30 PM EST
58.52USD-0.051%(-0.03)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Carlos, CA, USA
Previous Close
$59.40
Beta
1.30
52-Week High
$90.75 2026-10-05
52-Week Low
$42.40 2025-12-18
SMA 50
$62.23
SMA 200
$57.75
Avg. Vol 10D
1.36M
Avg. Vol 30D
2.40M
Avg. Vol 90D
1.82M
Relative Vol
0.47
158.30M
145.89M
15,359,758
0.2500%
1,600,000
26,979
PCVX Profile

sutrovax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. sutrovax's lead product candidate is a pneumococcal conjugate vaccine (pcv) that is designed to prevent invasive pneumococcal disease (ipd) caused by streptococcus pneumoniae. sutrovax's broad-spectrum pcv is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. the current mainstay vaccine only covers approximately 40% of the circulating strains causing ipd yet generates $6b in annual sales. sutrovax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum pcv compared head-to-head to current vaccines using well accepted immunological endpoints. in addition to its lead pcv product candidate, the company also has a promising early-stage pipeline addressing othe

PCVX Performance
PeriodPriceDateChangeBeta
1W68.622026-11-11-14.68%-0.712
1M63.682026-10-19-8.06%1.807
3M59.792026-08-18-2.07%1.975
6M48.442026-05-18+20.87%1.438
1Y49.532025-11-18+18.21%1.301
2Y86.492024-11-18-32.30%—
5Y24.532021-11-18+138.69%0.855
PCVX Stock Summary

Vaxcyte, Inc. Common Stock (NASDAQ:PCVX) stock price today is $58.55, and today's volume is 1,128,790. PCVX is down 1.431% today. The 30 day average volume is 2.40M. PCVX market cap is $9.27B with 158.30M shares outstanding.